A clinical trial to study the effect of enema therapy in chronic acid reflux.

Open label single arm clinical study to evaluate the effectiveness of Pittaghna Kala Basti in the management of Chirotha Amlapitta. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081049

Enrollment

Registered

2025-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Chronicity more than 6 months 2. Age group hetween 18-60 years either gender 3. Participants fit for Basti Karma 4. Participants who are willing to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Patients with history of systemic illness like diabetic mellitus and uncontrolled hypertension, immunodeficiency disorders like AIDS, and Carcinoma 3. Patients with Renal diseases, heart diseases, known case of hiatus hernia.

Design outcomes

Primary

Measure	Time frame
Assessment will be based on Samyak Basti Lakshanas, Retention time of Basti Dravya, and Number of Vegas for the procedure; and Avipaka (indigestion), Utklesha(nausea), Tikta-amla udgara (spicy-sour belching), Hrit-kantha daha (burning sensation in chest and throat) and Epigastric tenderness are to be assessed for Chirotha Amlapitta. Timepoint: 10days	—

Secondary

Measure	Time frame
Improvement in ease of lifestyleTimepoint: 25days	—

Countries

India

Contacts

Public ContactDr B A Lohith

SDM College of Ayurveda and Hospital

drlohithpk@gmail.com9886749168

Outcome results